Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic Raises $19.5 Million in Series C

NEW YORK, Feb. 20 - SomaLogic said today it has raised $19.5 million in a series C round of private financing.

 

The proteomics company plans to use the proceeds of the financing round to support R&D activities in development of its aptamer-based protein microarrays. Aptamers are single-stranded DNA molecules that bind specifically to target molecules.

 

The round was led by company insiders, who were joined by Japanese trading giant Mitsui & Co. and others. SomaLogic has an existing business development and Asian distribution partnership with Mitsui.

 

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.